32
BioTOPics 44 | May 2012
BioTOP-Report
Biomaterials
Biotechnologically Improved Biomaterials from
Berlin and Brandenburg
For decades, biomaterials have been an integral part of medical practice. The biologisation of biomaterials,
however, is a relatively new trend. Multifunctional polymer-based biomaterials are of high relevance, espe-
cially in biomaterial induced auto-regeneration. Berlin-Brandenburg is positioned excellently in the material
sciences field and is rapidly becoming a pacemaker for the newest generation of innovative biomaterials.
A great deal is happening in this field in the German Capital Re-
gion. Scientists at acclaimed institutions like the Max Planck In-
stitute of Colloids and Interfaces, the Fraunhofer Institute for Ap-
plied Polymer Research, the Centre for Biomaterial Development
of the HZG in Teltow, and Charité – Universitätsmedizin Berlin
are setting international standards in this field. The outstanding
networking between science and industry in the region permits
swift translation of the latest research findings into marketable
products. Alongside the big players in industry, small and mid-
sized companies which often emerged as university spin-offs play
a major role in these trailblazing activities.
A prime example of networked cooperation in the region is the
Helmholtz Virtual Institute (HVI) “Multifunctional Biomaterials
for Medicine” which was opened in December 2011. The HVI
“Multifunctional Materials for Medicine” is coordinated by the
Helmholtz Virtual Institute (HVI)
Multifunctional Materials for Medicine
Core Institutions
k
Helmholtz–Zentrum Geesthacht (HZG-Teltow),
Coordinating Centre
HVI spokesperson: Prof. Dr. Andreas Lendlein
k
Helmholtz-Zentrum Berlin (HZB)
HVI deputy spokesperson: Prof. Dr. Matthias Ballauff
k
Freie Universität Berlin (FUB/FUB-Charité)
HVI deputy spokesperson: Prof. Dr. Rainer Haag
k
Albert-Ludwigs-Universität Freiburg
Prof. Dr. Prasad Shastri
International Partners
k
Harvard University, Materials Research Science and
Engineering Centre, Cambridge (MA, USA)
k
The University of Tokyo, Centre for NanoBio Integration,
Tokyo ( Japan)
k
Sichuan University, National Centre for Biomaterials,
Chengdu (China)
Industrial Partners
k
mivenion GmbH, Berlin
k
Fresenius Medical Care Deutschland GmbH, Bad Homburg
Contact
Prof. Dr. Andreas Lendlein
Zentrum für Biomaterialentwicklung
Helmholtz-Zentrum Geesthacht
Kantstraße 55
14513 Teltow-Seehof
Phone: +49 3328 352450
andreas.lendlein@hzg.de
Prof. Dr. Andreas Lendlein
Centre for Biomaterial Development and
Berlin-Brandenburg Centre for Regenerative
Therapies · Helmholtz-Zentrum Geesthacht
Spokesperson of the HVI
Helmholtz Virtual Institutes, funded by the Helmholtz-Asso-
ciation of German Research Centres were initiated to com-
bine the key competencies of a university with those of one
or two Helmholtz-Centres. Freie Universität Berlin, Helmholtz-
Zentrum Berlin and HZG-Teltow are working together in the
HVI “Multifunctional Materials for Medicine” with the aim to
gain a comprehensive understanding of the complex protein-
biomaterial surface interactions in order to control the appli-
cation-relevant protein adsorption behavior in the future. Our
activities are integrated into the regional cluster "Healthcare
Industries Berlin-Brandenburg – HealthCapital".
33
BioTOPics 44 | May 2012
Biomaterials
BioTOP-Report
“Centre for Biomaterial Development” at the Helmholtz-Zentrum
Geesthacht/Campus Teltow (HZG-Teltow) and is one of twelve
new HVI initiatives, which were successfully evaluated in a highly
competitive process in July 2011.
Biomaterials in Regenerative Medicine
With the Centre for Biomaterial Development at the HZG-Teltow
and the Berlin-Brandenburg Center for Regenerative Therapies
(BCRT), the German Capital Region has excellent expertise in the
field of Regenerative Medicine. Here, fundamental research for
polymer based biomaterials meets application-motivated science
aiming at the translation of the knowledge gained into products
and clinical applications. Cooperation of scientists from different
disciplines is essential to perform research and develop bioma-
terials directed to clinical applications and products. This is the
aim of the BCRT as one of the centres for translational research
of the German Federal Ministry of Education and Research. This
joint initiative of Europe’s largest university hospital, the Charité,
and Germany’s largest research organization, the Helmholtz As-
sociation, is based on a highly interactive research program and
a consortium of internationally acknowledged experts in both ba-
sic and clinical science with more than 15 excellent institutional
partners.
The German Capital Region as pacemaker for
innovative biomaterials
There are other successful examples for biomaterials research
in Berlin-Brandenburg, such as the cooperation of the research
Dr. Ulla Peters or Reinhold Lauer
UHY Deutschland AG Wirtschaftsprüfungsgesellschaft/Zimmerstraße 23/D-10969 Berlin
Phone +49 30 226593-0/Fax +49 30 22679050/www.uhy-deutschland.de/www.uhy.com
Life sciences companies are in safe hands with UHY.
UHY Deutschland AG is a joint venture of long estab-
lished medium-sized auditing and consulting firms with
a total of 250 employees and partners.
As a member of UHY International, a global association
of independent accounting and consulting firms with
about 6,800 employees we can provide audit, account-
ing, tax and consulting services in 250 business centres
across the globe.
UHY Deutschland AG has extensive experience in finan-
cial and consulting services for life sciences companies
for many years. We offer the following services:
p
Audits of financial and consolidated statements
under the German Commercial Code (HGB) and
IFRS
p
Accounting & Reporting
p
Due diligence (financial and tax) and business
valuations
p
Consulting services on IPOs
p
Business Advisory
p
Mergers & Acquisitions (M&A)
p
German and international taxation
Berlin/Bremen/Cologne/Frankfurt/Hamburg/Munich/Stuttgart
Contact